SecBot SecBot
PRESS-RELEASE ·Filed Mar 3, 2026

NNOX

Nano-X Imaging Ltd
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

Monitor for future announcements of system installations or revenue generation from this territory; the lack of disclosed deal value or unit commitments limits near-term trading implications.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NNOX ▼ -24.32% at T+60d
NEUTRAL call -24.32% · α vs SPY -34.64% · entry $2.59 → $1.96
Entry = T+0 close
Mar 3, 2026
via day close
T+1d
+2.32%
call +2.32% · α +1.56%
$2.65
settled 8mo ago
T+5d
+1.54%
call +1.54% · α +2.02%
$2.63
settled 8mo ago
T+20d
-12.36%
call -12.36% · α -7.95%
$2.27
settled 7mo ago
T+60d
-24.32%
call -24.32% · α -34.64%
$1.96
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Nano-X Imaging announced a distribution agreement with Imperial Imaging to expand commercial rollout of its Nanox.ARC 3D imaging system across six U.S. Southeast states, targeting orthopedic and musculoskeletal (MSK) practices. The partnership leverages Imperial's regional expertise and established relationships to drive adoption of point-of-care imaging with existing reimbursement under a CPT code.

Key Facts

  • Nano-X subsidiary Nanox Impact Inc. signed a distribution agreement with Imperial Imaging Technology LLC.
  • Imperial will distribute Nanox.ARC systems and services in Georgia, Alabama, Tennessee, North Carolina, South Carolina, and Northern Florida.
  • Focus is on orthopedic and musculoskeletal (MSK) practices, enabling point-of-care 3D imaging with no pre-authorization required.
  • Nanox.ARC is reimbursable under an existing CPT code, reducing administrative burden.
  • Imperial Imaging is a Georgia-based diagnostic imaging solutions provider, recently named to the Inc. 5000 list.

Financial Impact

No financial terms disclosed — impact magnitude unknown

revenuemarket penetration

Risk Factors

  • No guaranteed sales volume or financial commitment disclosed in the agreement.
  • Commercial adoption of Nanox.ARC remains unproven at scale.
  • Execution risk in deployment and integration within clinical workflows.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3248256
19 reports for NNOX
Performance horizon
100% Hit rate @ T+20 6 of 6 directional calls Went positive at some point 9 of 9 best @ T+60▲ +56.28%Jul 28, 2026
Filters
Rows
Reports for NNOX — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
6-K
BEARISH ★ 7/10
$0.4100awaiting T+20—$0.3258 (+20.54%)
Oct 16, 2026
10d ago
Press Release
BEARISH ★ 7/10
$0.4100awaiting T+20—$0.3258 (+20.54%)
Oct 2, 2026
24d ago
6-K
BEARISH ★ 7/10
$0.6430awaiting T+20—$0.3258 (+49.33%)
Sep 9, 2026
6w ago
6-K
BEARISH ★ 7/10
$0.7800 $0.5950▲ +23.72%▲ +25.66%$0.3258 (+58.23%)
Aug 18, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$0.8869 $0.7537▼ −15.02%▼ −13.27%$0.3258 (−63.27%)
Aug 18, 2026
10w ago
6-K
BEARISH ★ 6/10
$0.8869 $0.7537▲ +15.02%▲ +13.27%$0.3258 (+63.27%)
Aug 7, 2026
11w ago
424B5
BEARISH ★ 7/10
$1.06 $0.8298▲ +21.72%▲ +21.32%$0.3258 (+69.26%)
Aug 4, 2026
12w ago
144
NEUTRAL ★ 2/10
$1.07 $0.7859▼ −26.55%▼ −25.31%$0.3258 (−69.55%)
Jul 28, 2026
12w ago
144
BEARISH ★ 5/10
$0.8772 $0.8758▲ +0.16%▲ +5.18%$0.3258 (+62.86%)
Jul 23, 2026
13w ago
6-K
BEARISH ★ 8/10
$0.8962 $0.8599▲ +4.05%▲ +7.68%$0.3258 (+63.65%)
Showing 10 of 19

US Market Status

Market Open — Closes in 1h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 3, 2026